Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K212262
    Device Name
    PCA Syringe Sets
    Date Cleared
    2022-10-03

    (440 days)

    Product Code
    Regulation Number
    880.5440
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    PCA Syringe Sets

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    For the administration of fluids from a container into the patient's vascular system through a vascular access device. For use in adult populations only.

    Device Description

    The proposed devices are patient controlled analgesia (PCA) syringe sets. They are single use disposable devices intended for the administration of fluids from a container into the patient's vascular system through a vascular access device. They are non-pyrogenic, sterile devices that can be directly attached to a syringe.

    The PCA syringe sets consist of non-DEHP PVC tubing/bushing, female luer cap, antisiphon valve with female luer, on-off clamp(s), male luer lock, male luer cap, back check valve with female luer (2P3331 and 2P3332 only), and y-connector (2P3331 and 2P3332 only). They are used to administer analgesics from a syringe to the patient IV access device (2P3331 and 2P3332 only) or from a syringe to a primary administration set (2P3333 only); and are also used to administer fluids from a container at the y-type connector (2P3331 and 2P3332 only).

    AI/ML Overview

    This document describes the acceptance criteria and the studies conducted to prove that Baxter Healthcare Corporation's PCA Syringe Sets meet these criteria, thereby demonstrating substantial equivalence to a predicate device.

    1. Table of Acceptance Criteria and Reported Device Performance:

    TestAcceptance CriteriaReported Device Performance
    Functional Performance (Bench Tests)All tests met acceptance criteria.
    ISO 80369-7 Tests on Male Luer Lock ConnectorISO 80369-7:2016, Clause 5 (as applicable), and Clauses 6.1, 6.2, 6.3, 6.4, 6.5, 6.6Met acceptance criteria
    ISO 80369-7 Tests on Female Luer Lock ConnectorISO 80369-7:2016, Clause 5 (as applicable), and Clauses 6.1, 6.2, 6.3, 6.4, 6.5, 6.6Met acceptance criteria
    Tensile Strength TestBS EN ISO 8536-9:2015, Clause 5.3Met acceptance criteria
    Leak TestBS EN ISO 8536-9:2015, Clause A.4Met acceptance criteria
    Counter Flow TestBS ISO 8536-12:2007+A1:2013, Clause A.4Met acceptance criteria
    Blocking Performance TestBS ISO 8536-12:2007+A1:2013, Clause A.6Met acceptance criteria
    Opening Pressure Test (Back Check Valve and Anti-Siphon Valve)BS ISO 8536-12:2007+A1:2013, Clause A.7.1 and per Baxter Test MethodMet acceptance criteria
    Particulate Matter TestUSP ChapterMet acceptance criteria
    Clamp Activation Force TestActivation force ≤ 50NMet acceptance criteria
    Clamp Shut-Off TestBS EN ISO 8536-14:2018, Clause A.1Met acceptance criteria
    Non-DEHP Claim VerificationPer Baxter Test Method (as tested in K161808)Met acceptance criteria
    BiocompatibilityDevice met the designated ISO 10993-1 categorization and is biocompatible for intended use.Met acceptance criteria
    CytotoxicityISO 10993-5Met acceptance criteria
    SensitizationISO 10993-10Met acceptance criteria
    Intracutaneous (Irritation) ReactivityISO 10993-10Met acceptance criteria
    Systemic Toxicity (acute and repeat dose)ISO 10993-11Met acceptance criteria
    Material Mediated PyrogenISO 10993-11Met acceptance criteria
    GenotoxicityISO 10993-3Met acceptance criteria
    HemolysisISO 10993-4Met acceptance criteria
    SterilitySterility Assurance Level (SAL) of 10⁻⁶Met acceptance criteria (validated)
    Bacterial endotoxins testsUSP , Endotoxin limit of 20 EU/device per USPMet acceptance criteria
    Shelf Life3 (three) years of shelf lifeSupported (aging testing performed)
    Microbial Ingress TestingAbsence of microbial ingress to the sterile fluid path (following Baxter's testing strategy, K180739)Met acceptance criteria

    2. Sample size used for the test set and the data provenance:

    The document does not explicitly state the exact sample sizes used for each individual performance test (e.g., number of devices tested for leak, tensile strength, etc.). It generally states that "All tests met the acceptance criteria" and that "Baxter Healthcare Corporation conducts risk analyses and design verification tests based on the result of these analyses."

    The data provenance is implied to be from internal laboratory testing conducted by Baxter Healthcare Corporation. No information is provided regarding the country of origin of the data or whether the studies were retrospective or prospective. Given the nature of these tests (bench tests, biocompatibility, sterility, shelf life), they are typically prospective studies performed in a controlled laboratory environment.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

    This information is not applicable. The studies described are primarily engineering performance tests, biocompatibility assessments, and sterility validations, which rely on industry standards (ISO, BS EN, USP) and predefined acceptance criteria rather than expert-established ground truth in the context of clinical interpretation or diagnosis.

    4. Adjudication method (e.g., 2+1, 3+1, none) for the test set:

    This information is not applicable. The tests performed are objective measurements and validations against specified standards, not subjective assessments requiring adjudication by multiple experts.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

    This is not applicable. The device (PCA Syringe Sets) is a medical administration set, not an AI-powered diagnostic or assistive tool. Therefore, MRMC studies involving human readers or AI assistance are irrelevant to this device.

    6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done:

    This is not applicable. The device is a physical medical administration set, not an algorithm.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):

    The "ground truth" for the performance of the device is established by adherence to recognized national and international engineering and medical device standards, such as ISO 80369-7, BS EN ISO 8536-9, BS ISO 8536-12, BS EN ISO 8536-14, USP Chapters and , USP , ISO 10993 series, and ANSI/AAMI/ISO 11137 series. These standards define the acceptable range of performance for specific physical and biological characteristics of the device.

    8. The sample size for the training set:

    This is not applicable. The device is a physical product and not an AI/ML algorithm that requires a training set.

    9. How the ground truth for the training set was established:

    This is not applicable because there is no training set for this device.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1